Efficient Neutralizing Antibodies Induction by Human Parvovirus B19 Epitope-Presenting Protein Nanoparticles

Area of Science:

• Virology
• Immunology
• Nanotechnology

Background:

• Human parvovirus B19 (B19V) is a significant pathogen causing fetal hydrops in pregnant women.
• Current effective vaccine strategies against B19V remain underdeveloped.

Purpose of the Study:

• To engineer B19V protein nanoparticles for enhanced immunogenicity.
• To evaluate the efficacy of these nanoparticles as potential vaccine candidates.

Main Methods:

• Fusion of the B19V VP1 N-terminal receptor-binding domain (VP1u 5-80) with self-assembling protein nanoparticles.
• Characterization of nanoparticle assembly using gel filtration and electron microscopy.
• Assessment of nanoparticle binding to B19V target cells (UT7/Epo-S1).
• Immunization of mice with nanoparticles and evaluation of antibody production and neutralizing activity.

Main Results:

• Successfully engineered spherical B19V antigen-fused nanoparticles.
• Nanoparticles demonstrated efficient binding to susceptible host cells.
• Immunization with nanoparticles induced robust B19V-specific IgG antibody production in mice.
• Antibodies generated by nanoparticle immunization showed enhanced B19V infection-neutralizing activity.

Conclusions:

• Nanoparticle formation significantly enhances the immunogenicity of the B19V VP1u 5-80 peptide.
• Engineered B19V nanoparticles represent promising vaccine candidates for inducing immunity against B19V.
• This approach offers a potential strategy to combat B19V-related health issues, including fetal hydrops.